ThermoBreast is a 4-year project involving a multidisciplinary consortium of 19 international partners from 11 countries. It aims to contribute to the European Union’s Mission on Cancer and Beating Cancer Plan, striving to drastically improve the prevention, diagnosis and monitoring of breast cancer, as well as reduce the burden on female patients, their families, healthcare professionals, and all others affected by breast cancer directly or indirectly.
ThermoBreast is funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them (grant agreement no. 101096329).
Swiss participants in this project are supported by the Swiss State Secretariat for Education, Research and Innovation (contract no. 22.00518).
Company Details
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://thermobreast.eu/
Thermobreast Questions
Thermobreast's website is https://thermobreast.eu/
Thermobreast's LinkedIn profile is https://www.linkedin.com/company/thermobreast
Thermobreast's industry is
Research Services
Thermobreast's top competitors are
Novu,
Northmed Employment Center,
Idiscam | Fundación Del Hospital Nacional De Parapléjicos,
Mammoscreen Project,
Fortunesse,
Novu Ai 20,
Ambrosia Project,
Raise Science,
Aigea Medical,
Thermomind.
Thermobreast's categories are Research Services
